NCT06947668View on ClinicalTrials.gov

Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel

Not yet recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

June 1, 2030

Study Completion Date

December 31, 2030

Conditions
Squamous Cell Carcinoma of OropharynxSquamous Cell Carcinoma of the HypopharynxLarynx Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
Trial Locations (1)

91054

Universitätsklinikum Erlangen, Strahlenklinik, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER